These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3677569)

  • 1. Effect of metoclopramide on the absorption of an oral sustained-release quinidine product.
    Yuen GJ; Hansten PD; Collins J
    Clin Pharm; 1987 Sep; 6(9):722-5. PubMed ID: 3677569
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative multiple dose pharmacokinetics of quinine, quinidine and quinidine sustained release.
    Jamaludin A; Mohamad M; Navaratnam V; Mohamed N; Yeoh PY; Wernsdorfer WH
    Acta Leiden; 1989; 58(2):129-40. PubMed ID: 2489392
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of quinidine following the administration of a single intravenous dose or single and repeated oral doses in human subjects].
    Leucuţa SE; Zdrenghea D; Poruţiu D; Stăncioiu N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(3):253-8. PubMed ID: 2891173
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution.
    Sawyer WT; Pulliam CC; Mattocks A; Foster J; Hadzija BW; Rosenthal HM
    Biopharm Drug Dispos; 1982; 3(4):301-10. PubMed ID: 7159686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administered oral metoclopramide does not enhance the rate of absorption of oral diazepam.
    Chapman MH; Woolner DF; Begg EJ; Atkinson HC; Sharman JR
    Anaesth Intensive Care; 1988 May; 16(2):202-5. PubMed ID: 3394914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diphenoxylate with atropine sulfate on the bioavailability of quinidine sulfate in healthy subjects.
    Ponzillo JJ; Scavone JM; Paone RP; Lewis GP; Rayment CM; Fitzsimmons WE
    Clin Pharm; 1988 Feb; 7(2):139-42. PubMed ID: 3349749
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.
    Wing LM; Meffin PJ; Grygiel JJ; Smith KJ; Birkett DJ
    Br J Clin Pharmacol; 1980 May; 9(5):505-9. PubMed ID: 6994791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of laxatives and metoclopramide on plasma quinidine concentration during prolonged administration in patients with heart rhythm disorders].
    Guckenbiehl W; Gilfrich HJ; Just H
    Med Welt; 1976 Jun; 27(26):1273-6. PubMed ID: 933817
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary salt increases first-pass elimination of oral quinidine.
    Darbar D; Dell'Orto S; Mörike K; Wilkinson GR; Roden DM
    Clin Pharmacol Ther; 1997 Mar; 61(3):292-300. PubMed ID: 9084454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.
    Citron ML; Reynolds JR; Kalra J; Kay BG; Nathan KA; Jaffe ND; Miller FR
    Cancer Treat Rep; 1987 Mar; 71(3):317-9. PubMed ID: 3815397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid elimination of quinidine in pediatric patients.
    Szefler SJ; Pieroni DR; Gingell RL; Shen DD
    Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metoclopramide on the pharmacokinetics of a slow-release theophylline product.
    Steeves RA; Robinson JD; McKenzie MW; Justus PG
    Clin Pharm; 1982; 1(4):356-60. PubMed ID: 7185530
    [No Abstract]   [Full Text] [Related]  

  • 16. Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies.
    Kitamura Y; Koto H; Matsuura S; Kawabata T; Tsuchiya H; Kusuhara H; Tsujimoto H; Sugiyama Y
    Drug Metab Dispos; 2008 May; 36(5):807-10. PubMed ID: 18299336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of quinidine Lipettes -- a sustained release preparation.
    Eriksson JE; Hanson A; Hörlin R; Johansson BW; Ohlsson O; Otto U; Syrén G
    Acta Med Scand; 1979; 205(1-2):53-9. PubMed ID: 367087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental model for the rational treatment of arrhythmias: a clinical study with quinidine].
    Pelosi G; Duca G; Bareggi SR; Pirola R; Hadëri B
    G Ital Cardiol; 1993 Aug; 23(8):777-86. PubMed ID: 8119501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug absorption from in situ rat small intestine during metoclopramide administration.
    Venho VM
    J Pharm Sci; 1979 Apr; 68(4):517-8. PubMed ID: 438985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of a standard and a sustained-release quinidine tablet.
    Gibson DL; Smith GH; Koup JR; Stewart DK
    Clin Pharm; 1982; 1(4):366-8. PubMed ID: 7185532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.